TickerFacts.

Fortrea Holdings Inc. (FTRE): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.72B
Year ended 2025-12-31
$2.68B
Trailing 12 months to 2026-06-30
-1.4%
3-year compound annual growth
$3.06B2021-12-31: $3.06B2022-12-31: $2.84B2023-12-31: $2.84B2024-12-31: $2.70B2025-12-31: $2.72B$2.72B
2021-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$2.72B+1.0%2026-02-26, From 2025-01-01
2024-12-31$2.70B-5.1%2026-02-26, From 2024-01-01
2023-12-31$2.84B+0.2%2026-02-26, From 2023-01-01
2022-12-31$2.84Bn/c2025-03-03, From 2022-01-01
2021-12-31$3.06Bn/a2024-03-13, From 2021-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Fortrea Holdings Inc. (FTRE)2025-12-31$2.72B+1.0%
Natera, Inc. (NTRA)2025-12-31$2.31B+35.9%
RadNet, Inc. (RDNT)2025-12-31$2.04B+11.5%
Guardant Health, Inc. (GH)2025-12-31$982.02M+32.9%
Caris Life Sciences, Inc. (CAI)2025-12-31$812.03M+97.0%
Quest Diagnostics Inc (DGX)2025-12-31$11.04B+11.8%
Labcorp Holdings Inc. (LH)2025-12-31$13.95B+7.2%
Veracyte, Inc. (VCYT)2025-12-31$517.14M+16.0%
CareDx, Inc. (CDNA)2025-12-31$379.81M+13.8%

Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗